The Medicines Company

(MDCO) Trade

By |

Profile

The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.

Contact Information

Website: www.themedicinescompany.com
Email: krishna.gorti@themedco.com
Main Phone: +1 973 290-6000
Address: 8 Sylvan Way
State: NJ
City / Town: Parsippany
Country: USA
Postal Code: 07054

Issuer Information

Exchange: NGS
CEO: Mark Timney
Employees: 62
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.

Contact Information

Website: www.themedicinescompany.com
Email: krishna.gorti@themedco.com
Main Phone: +1 973 290-6000
Address: 8 Sylvan Way
State: NJ
City / Town: Parsippany
Country: USA
Postal Code: 07054

Issuer Information

Exchange: NGS
CEO: Mark Timney
Employees: 62
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 35.83 $ 0.01 (0.03%)
Last Price 35.83 Change $ 0.01 Change % 0.03 Tick N/A
Bid 35.83 Bid Size 100.00 Ask 50.00 Ask Size 100.00
Open 36.07 High 36.40 Low 35.58 Prev Close 35.82
Last Trade Volume 1.1 mi 52 Wk Hi 41.57 52 Wk Low 16.69
Market Cap 2.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 73,899,749.00 EPS (TTM) -2.87 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 14 42
Number of Buys 11 33
Number of Sells 3 9
Net Activity 50185 463731
Last 10 Buys Shares
Fredric N. Eshelman 1,000
Fredric N. Eshelman 1,000
Paris Panayiotopoulos 1,000
Alexander J. Denner, 1,000
Fredric N. Eshelman 1,000
Fredric N. Eshelman 1,000
Christopher T. Cox 1,000
Fredric N. Eshelman 1,000
Christopher T. Cox 1,000
Fredric N. Eshelman 1,000
Last 10 Sell Shares
Melvin K. Spigelman 1,000
Armin M. Kessler 1,000
William W. Crouse 1,000
Armin M. Kessler 1,000
William B. O'Connor 1,000
William B. O'Connor 1,000
William B. O'Connor 1,000
William B. O'Connor 1,000
William B. O'Connor 1,000
William B. O'Connor 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 55 54 54 55
Low Target Price Estimate 39 39 39 39
Mean Target Price Estimate 47.11 46.13 46.13 47.11
Standard Deviation 5.18 4.55 4.55 5.18
Date of Most Recent Estimate 06/07/18 05/02/18 05/02/18 06/07/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 9 8 8 8
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.22 1.22 1.22